Esomeprazole Sodium API Pharma Grade Powder Anti-Ulcer CAS#161796-78-7

• Customization: Available
• Function: Hormones and Regulation of Endocrine Function of Drug, Antibiotic and Antimicrobial Agents, Antiparasitic, Immune System Drugs, Specialist Drugs, Drug Detoxification, Diagnostic Agents, Nervous System Drugs, Blood System Agents, Enzymes and Other Biochemical, Visceral System Medication, Cardiovascular Agents, Urinary System Agents, Antidote
• Certification: GMP, Reach, FDA
• Model NO.: CAS#161796-78-7
• Grade Standard: Medicine Grade
• Type: Chemical Reagent
• State: Solid
• Volatile: Not Volatile
• CAS#: 161796-78-7
• Product Name: Esomeprazole Sodium
• Colour: White
• Capacity: 1ton/Month
• Transport Package: According to Customer Requirements
• Specification: Customized on demand
• Trademark: none
• Origin: China

Product Description

Product Description

 

Product Name:	Esomeprazole sodium
Synonyms:	(S)-OMeprazolesodiuM;1H-BENZIMIDAZOLE,5-METHOXY-2-[[(4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL]SULFINYL]-,SODIUMSALT;ESOMEPRAZOLESODIUM;Esomeprazoleandsalts;5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl-1H-benzChemicalbookimidazolesodiumsalt;SodiuM(S)-6-Methoxy-2-(((4-Methoxy-3,5-diMethylpyridin-2-yl)Methyl)sulfinyl)benzo[d]iMidazol-1-ide;odiuM(R)-6-Methoxy-2-(((4-Methoxy-3,5-diMethylpyridin-2-yl)Methyl)sulfinyl)benzo[d]iMidazol-1-ide;EsoMeprazolesod
CAS No.	161796-78-7
Formula:	C34H36MgN6O6S2
Formula Weight:	713.12
Appearance:	Powder
Color:	White
Solubility:	DMSO (Slightly, Sonicated), Me thanol (Slightly), Water (Slightly)
Storage:	2-8°C

Factory Profile

 

 

Company Profile

 

Chengdu Medi-sourcing International Trade Co., Ltd. is one of the subsidiaries of Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.(Luoxin Group), responsible for the export business of all products from Luoxin Group and others agent products.
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. is a healthcare conglomerate that is engaged in pharmaceutical research and development, manufacture, sales, and healthcare service. There are six manufacturing sites covering formulations, APIs and Intermediates, Chinese medicine and its extracts and Medical apparatus and instruments products. Benefiting from the layout structure of the whole industry chain, Luoxin Pharmaceutical has a strong development momentum and successfully listed on the A-share market in 2019.